nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Hypertonia—Doxorubicin—muscle cancer	0.00247	0.00247	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Etoposide—muscle cancer	0.00246	0.00246	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Etoposide—muscle cancer	0.00246	0.00246	CcSEcCtD
Gadobenate Dimeglumine—Abnormal vision—Doxorubicin—muscle cancer	0.00245	0.00245	CcSEcCtD
Gadobenate Dimeglumine—Chills—Etoposide—muscle cancer	0.00245	0.00245	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00244	0.00244	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Vincristine—muscle cancer	0.00239	0.00239	CcSEcCtD
Gadobenate Dimeglumine—Infection—Vincristine—muscle cancer	0.00237	0.00237	CcSEcCtD
Gadobenate Dimeglumine—Phlebitis—Doxorubicin—muscle cancer	0.00237	0.00237	CcSEcCtD
Gadobenate Dimeglumine—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.00235	0.00235	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Vincristine—muscle cancer	0.00234	0.00234	CcSEcCtD
Gadobenate Dimeglumine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00234	0.00234	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Etoposide—muscle cancer	0.00232	0.00232	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Vincristine—muscle cancer	0.00231	0.00231	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Dactinomycin—muscle cancer	0.00231	0.00231	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Etoposide—muscle cancer	0.00229	0.00229	CcSEcCtD
Gadobenate Dimeglumine—Pain—Dactinomycin—muscle cancer	0.00229	0.00229	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Etoposide—muscle cancer	0.00228	0.00228	CcSEcCtD
Gadobenate Dimeglumine—Eye pain—Doxorubicin—muscle cancer	0.00226	0.00226	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00225	0.00225	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Vincristine—muscle cancer	0.00223	0.00223	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Dactinomycin—muscle cancer	0.0022	0.0022	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Etoposide—muscle cancer	0.0022	0.0022	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Etoposide—muscle cancer	0.00219	0.00219	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00219	0.00219	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Methotrexate—muscle cancer	0.00218	0.00218	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00218	0.00218	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Vincristine—muscle cancer	0.00215	0.00215	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Etoposide—muscle cancer	0.00214	0.00214	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis bullous—Doxorubicin—muscle cancer	0.00214	0.00214	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Etoposide—muscle cancer	0.00212	0.00212	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Dactinomycin—muscle cancer	0.00211	0.00211	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Dactinomycin—muscle cancer	0.00211	0.00211	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Gadobenate Dimeglumine—Hypoglycaemia—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Etoposide—muscle cancer	0.00208	0.00208	CcSEcCtD
Gadobenate Dimeglumine—Cough—Etoposide—muscle cancer	0.00207	0.00207	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00206	0.00206	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Vincristine—muscle cancer	0.00206	0.00206	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Doxorubicin—muscle cancer	0.00205	0.00205	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Etoposide—muscle cancer	0.00205	0.00205	CcSEcCtD
Gadobenate Dimeglumine—Pain—Vincristine—muscle cancer	0.00204	0.00204	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Vincristine—muscle cancer	0.00204	0.00204	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Doxorubicin—muscle cancer	0.00204	0.00204	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Methotrexate—muscle cancer	0.00204	0.00204	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Etoposide—muscle cancer	0.00202	0.00202	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Doxorubicin—muscle cancer	0.00201	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00201	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Etoposide—muscle cancer	0.002	0.002	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Dactinomycin—muscle cancer	0.00197	0.00197	CcSEcCtD
Gadobenate Dimeglumine—Abdominal discomfort—Methotrexate—muscle cancer	0.00196	0.00196	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Vincristine—muscle cancer	0.00195	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Etoposide—muscle cancer	0.00195	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Etoposide—muscle cancer	0.00194	0.00194	CcSEcCtD
Gadobenate Dimeglumine—Infection—Etoposide—muscle cancer	0.00192	0.00192	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dactinomycin—muscle cancer	0.00192	0.00192	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Etoposide—muscle cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Vincristine—muscle cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Vincristine—muscle cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Etoposide—muscle cancer	0.00188	0.00188	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Etoposide—muscle cancer	0.00187	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dactinomycin—muscle cancer	0.00183	0.00183	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Methotrexate—muscle cancer	0.00182	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Methotrexate—muscle cancer	0.00182	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Etoposide—muscle cancer	0.00181	0.00181	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.0018	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Methotrexate—muscle cancer	0.00179	0.00179	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Methotrexate—muscle cancer	0.00177	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Doxorubicin—muscle cancer	0.00177	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Vincristine—muscle cancer	0.00176	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Methotrexate—muscle cancer	0.00174	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Etoposide—muscle cancer	0.00174	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Methotrexate—muscle cancer	0.00173	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Etoposide—muscle cancer	0.00173	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Etoposide—muscle cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Vincristine—muscle cancer	0.00171	0.00171	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Dactinomycin—muscle cancer	0.0017	0.0017	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dactinomycin—muscle cancer	0.00169	0.00169	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00167	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Etoposide—muscle cancer	0.00167	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Pain—Etoposide—muscle cancer	0.00166	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Etoposide—muscle cancer	0.00166	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Vincristine—muscle cancer	0.00164	0.00164	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Methotrexate—muscle cancer	0.0016	0.0016	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Etoposide—muscle cancer	0.0016	0.0016	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dactinomycin—muscle cancer	0.00159	0.00159	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Etoposide—muscle cancer	0.00158	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Vincristine—muscle cancer	0.00158	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Etoposide—muscle cancer	0.00154	0.00154	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Etoposide—muscle cancer	0.00153	0.00153	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Etoposide—muscle cancer	0.00153	0.00153	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Methotrexate—muscle cancer	0.00153	0.00153	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vincristine—muscle cancer	0.00152	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Rash—Vincristine—muscle cancer	0.00151	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Vincristine—muscle cancer	0.00151	0.00151	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vincristine—muscle cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—muscle cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Etoposide—muscle cancer	0.00143	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vincristine—muscle cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—muscle cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Etoposide—muscle cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—muscle cancer	0.00137	0.00137	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—muscle cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—muscle cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—muscle cancer	0.00127	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Etoposide—muscle cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—muscle cancer	0.00122	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—muscle cancer	0.00122	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Headache—Etoposide—muscle cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—muscle cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—muscle cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—muscle cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.0012	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—muscle cancer	0.0012	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—muscle cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—muscle cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—muscle cancer	0.00116	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etoposide—muscle cancer	0.00115	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—muscle cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—muscle cancer	0.00112	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—muscle cancer	0.0011	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—muscle cancer	0.0011	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—muscle cancer	0.00109	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—muscle cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—muscle cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—muscle cancer	0.00102	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—muscle cancer	0.001	0.001	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.001	0.001	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—muscle cancer	0.001	0.001	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—muscle cancer	0.000998	0.000998	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—muscle cancer	0.000992	0.000992	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—muscle cancer	0.000988	0.000988	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—muscle cancer	0.000985	0.000985	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—muscle cancer	0.00098	0.00098	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—muscle cancer	0.000975	0.000975	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000971	0.000971	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—muscle cancer	0.000956	0.000956	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000948	0.000948	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—muscle cancer	0.000938	0.000938	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—muscle cancer	0.000921	0.000921	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—muscle cancer	0.000917	0.000917	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—muscle cancer	0.000917	0.000917	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000915	0.000915	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—muscle cancer	0.000902	0.000902	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—muscle cancer	0.000895	0.000895	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—muscle cancer	0.000893	0.000893	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—muscle cancer	0.000884	0.000884	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000867	0.000867	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—muscle cancer	0.000866	0.000866	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—muscle cancer	0.000859	0.000859	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—muscle cancer	0.000859	0.000859	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—muscle cancer	0.000854	0.000854	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—muscle cancer	0.000832	0.000832	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—muscle cancer	0.000827	0.000827	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000821	0.000821	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—muscle cancer	0.00082	0.00082	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—muscle cancer	0.000798	0.000798	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—muscle cancer	0.000794	0.000794	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—muscle cancer	0.000794	0.000794	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—muscle cancer	0.000793	0.000793	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—muscle cancer	0.000767	0.000767	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—muscle cancer	0.00074	0.00074	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—muscle cancer	0.000737	0.000737	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—muscle cancer	0.000731	0.000731	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—muscle cancer	0.000731	0.000731	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—muscle cancer	0.000726	0.000726	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—muscle cancer	0.00072	0.00072	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—muscle cancer	0.00071	0.00071	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—muscle cancer	0.000689	0.000689	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—muscle cancer	0.000687	0.000687	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—muscle cancer	0.000664	0.000664	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—muscle cancer	0.000638	0.000638	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—muscle cancer	0.000633	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—muscle cancer	0.000633	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—muscle cancer	0.000629	0.000629	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—muscle cancer	0.000596	0.000596	CcSEcCtD
